LONDON, Jan. 9, 2026 /PRNewswire/ -- M&G Investments (M&G) today announces that it has led a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pioneering ...

LONDON, Jan. 9, 2026 /PRNewswire/ -- M&G Investments (M&G) today announces that it has led a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pioneering ...

None ...

bit.bio, the global leader in cell programming technology, is creating functional, human-relevant cells and models at industrial scale to accelerate research, drug discovery and development, while ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

There are a number of athletes representing Team USA in Italy across various age groups. Here are the oldest and youngest ...

The company's 10-Ks for fiscal year 2025 identify certain factors that could cause the company's actual results to differ ...

Bit Bio Ltd., a synthetic biology company providing human cells for research, announced the close of its $50 million Series C funding round led by M&G Investments. Cambridge, United Kingdom-based Bit ...

Q2 2026 Earnings Call February 4, 2026 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...